ファイザーCEO Albert Bourla credits a specific AI-driven change for improving his sleep quality and reducing stress. In a recent interview with the Wall Street Journal, Bourla revealed that implementing an AI-powered scheduling system helped him reclaim evenings and weekends. The tool automatically prioritizes critical meetings and blocks uninterrupted focus time, preventing the constant interruptions that once fueled his insomnia.
Bourla described the shift as a "game-changer" for work-life balance, allowing him to disconnect without missing key decisions. The system, developed internally at Pfizer, is now being evaluated for broader rollout across executive leadership. Bourla emphasized that the technology doesn't replace human judgment but rather augments it by filtering noise.
He noted that the change also improved team productivity, as fewer unnecessary meetings freed up staff for strategic work. The AI initiative reflects a growing trend among pharma giants to use machine learning for operational efficiency. Bourla, who has led Pfizer since 2019, said the innovation aligns with the company's mission to "heal" not just patients but also the burnout culture of corporate America.
出典: Wall Street Journal US Business · 要約：HeadlinesBriefing